Intense immunostaining for
pregnancy-associated plasma protein-A (
PAPP-A), a newly characterized
metalloproteinase in the
insulin-like growth factor system, colocalizes with activated macrophages in human
atherosclerotic plaque. To determine macrophage regulation of
PAPP-A expression, we developed two models of human macrophages with basal and activated phenotypes. THP-1 cells and peripheral blood monocytes could be differentiated into macrophages and activated upon specific treatment regimens with
phorbol myristate acetate,
macrophage colony-stimulating factor, and
interleukin-1beta. Activation was assessed by cell secretion of
tumor necrosis factor-alpha, which increased 30- to 100-fold with activation. Activated macrophages also secreted
matrix metalloproteinase-9. However, no
PAPP-A mRNA or
PAPP-A antigen could be detected in these cells under any condition. Upon incubation with recombinant
PAPP-A, we found that activated macrophages bound and internalized more
PAPP-A than unactivated macrophages or monocytes. Internalization accounted for at least 50% of macrophage-associated
PAPP-A, as assessed in studies with
cytochalasin B. Membrane-bound
PAPP-A retained
protease activity, whereas internalized
PAPP-A had little or no activity. Similar experiments carried out with a mutated variant of
PAPP-A, which retains functionality as a
protease but is unable to bind surface-associated
glycosaminoglycan, showed no macrophage association or internalization. Absence of
PAPP-A expression was confirmed in activated macrophages isolated from a hypercholesterolemic rabbit model of
atherosclerosis. We therefore conclude that
PAPP-A is not synthesized in, but rather is bound and internalized by, macrophages. Our findings likely account for the observed intense immunostaining for
PAPP-A colocalizing with activated macrophages and may have physiological significance in the development of vulnerable plaque.